TIPPED IN SHARES MAG : share for 2002

Having jumped in this morning I have now had time to do lots of research on this share and see a very solid product with good future potential. I paste this from the iii board which seems solid

1) FDA Approval HAS been given.
2) OMH have enough money till the END of 2002.
3) An upfront license fee of around $15m is expected for the UTI device.
4) Commercial partnership talks are in an advanced stage.
5) BV approval WILL come through in 2002.
6) OMH have first mover advantage in a market (for their FIRST product) worth $1.5bn WORLDWIDE.
7) OMH have patents galore on their platform technology.
8) OMH will have a regular source of ongoing income from royalties PLUS disposables (spares).
9) Broker targets range from 28p to 87p NOW, with the CEO saying they are worth over £1 a share.
10) OMH (imho) will be contacted by large companies regarding their core technology to do deals whereby trials will be funded for additional diseases etc in return for a commercial partnership once completed.
11) Forget about the short term share price, DO NOT UNDERESTIMATE what the approval of the platform technology will be worth in revenues globally in 3-5years. This is a future FTSE100 contender if not taken out early by a multinational.

Whilst I never look to the top end price targets I take about 50% off usually and find this to be fairly reliable. Having jumped in looking for a quick killing I think I shall be staying a while to see where this one goes.